Atlas Trials

Familial Amyloidotic Polyneuropathy (FAP)

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Familial Amyloidotic Polyneuropathy (FAP)

RecordFirmDate
The Study of an Investigational Drug, Revusiran (ALN-TTRSC), for the Treatment of Transthyretin (TTR)-Mediated Amyloidosis in Patients Whose Disease Has Continued to Worsen Following Liver Transplant (NCT02595983)Alnylam Pharmaceuticals2015-10-01

Track Familial Amyloidotic Polyneuropathy (FAP) automatically

Every clearance here is in the API, with alerts when new ones post.